eNauka - pregled

Pregled prema Autor Fountzilas, G.

Prikaz rezultata 1 do 2 od 2
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2004Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients - medical resource utilization (MRU) data from a large phase III trial (X-ACT)McKendrick, J. J.; Cassidy, J.; Chakrapee-Sirisuk, S.; Fountzilas, G.; Iveson, T.; Jelić, Svetislav  ; Kamicka-Mlodkowska, H.; Ostojić, R.; Scheithauer, W.; Twelves, C.Conference Paper
Mp. category will be shown later
2006Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer - the X-ACT trialCassidy, J.; Douillard, Y.; Twelves, C.; McKendrick, J. J.; Scheithauer, W.; Bustova, I.; Johnston, P. G.; Lesniewski-Kmak, L.; Jelić, Svetislav  ; Fountzilas, G.;
Coxon, F.; Diaz-Rubio, E.; Maughan, T. S.; Malzyner, A.; Bertetto, O.; Beham, A.; Figer, A.; Dufour, P.; Patel, K. K.; Cowell, W.; Garrison, L. P.;
Article
21M21